Table 3.
Comparative analysis of HMC morphologic variants in glioma-affected and unaffected hemispheres.
| Unaffected |
Total | |||||
|---|---|---|---|---|---|---|
| Ω | ε | Ω-ε | ε-Ω | |||
| Affected | Ω | 128 (46.4) | 22 (8.0) | 7 (2.5) | 0 (0.0) | 157 (56.9) |
| ε | 16 (5.8) | 58 (21.0) | 5 (1.8) | 0 (0.0) | 79 (28.6) | |
| Ω-ε | 10 (3.6) | 4 (1.4) | 23 (8.4) | 0 (0.0) | 37 (13.4) | |
| ε-Ω | 2 (0.7) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 3 (1.1) | |
| Total | 156 (56.5) | 85 (30.8) | 35 (12.7) | 0 (0.0) | 276 | |
No significant difference was observed in the morphological incidence of HMC between affected and unaffected cerebral hemispheres (p = 0.3507, Chi-square test).